Android app on Google Play

Amgen (AMGN) Price Target Raised to $138 at Deutsche Bank

August 26, 2013 1:50 PM EDT Send to a Friend
Get Alerts AMGN Hot Sheet
Price: $140.68 -1.06%

Rating Summary:
    14 Buy, 14 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 21 | New: 42
Trade AMGN Now!
Join SI Premium – FREE
Deutsche Bank today maintained a Buy on Amgen (NASDAQ: AMGN) and raised its price target to $138.00 (from $115.00). Analyst Robyn Karnauskas thinks the company's acquisition of Onyx (Nasdaq: ONXX) will create value.

"We expect this deal to be -2% dilutive for AMGN in 2014 and 3% accretive in 2015. Our calculations suggest significant annual accretion (>20%) post 2018. We model ~25% synergies for ONXX SG&A & R&D, which should save ~$225M annually at peak. We see 2014/2015/2016 EPS at $8.43/$9.09/$9.51 vs. $8.53/$8.87/$8.84 previously. We now see AMGN Revenues and EPS growing at CAGRs of 3% & 9%, respectively (previously 0% and 5%) by 2020," said Karnauskas.

For an analyst ratings summary and ratings history on Amgen (NASDAQ: AMGN) click here. For more ratings news on Amgen click here.

Shares of Amgen closed at $105.60 yesterday.

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Deutsche Bank, Definitive Agreement

Add Your Comment